Translating tolerogenic therapies to the clinic – where do we stand and what are the barriers?

127K

views

74

authors

18

articles

Translating tolerogenic therapies to the clinic – where do we stand and what are the barriers?

127K

views

74

authors

18

articles

Editors

2

Stephen Paul Cobbold

University of Oxford

Houston Methodist Hospital

Impact

About

This Research Topic is a call for papers to provide an up to date assessment of current attempts to introduce tolerogenic therapies into clinical practice. Tolerance has been a highly sought after goal in the field of organ transplantation for over half a century, and is now readily achievable in rodent models, but considerable barriers remain to successfully translating tolerogenic treatments to the clinic.

The initial call for this Research Topic has been aimed to provide an overview of recent advances made within the European RISET and American ITN networks with regard to tolerogenic strategies in clinical transplantation, autoimmune disease, and allergy. Articles will also cover the barriers to clinical tolerance induction and new emerging approaches to overcome such barriers.

1. Collaborative networks working towards the goal of therapeutic tolerance induction

2. Prope tolerance and minimization of immunosuppression

3. Lessons from operationally tolerant patients

4. Targeted withdrawal of immunosuppression

5. Stem cells and hematopoietic chimerism as a route to tolerance

6. Promoting regulatory T cells

7. Tolerogenic dendritic cells and negative vaccination

8. Inhibitory pathways and mechanisms in tolerance

9. Memory T cells and heterologous immunity

10. The innate response to allotransplants

11. Chronic graft loss--what are the missing links?

12. The impact of graft microenvironment on tolerance

This Research Topic is a call for papers to provide an up to date assessment of current attempts to introduce tolerogenic therapies into clinical practice. Tolerance has been a highly sought after goal in the field of organ transplantation for over half a century, and is now readily achievable in rodent models, but considerable barriers remain to successfully translating tolerogenic treatments to the clinic.

The initial call for this Research Topic has been aimed to provide an overview of recent advances made within the European RISET and American ITN networks with regard to tolerogenic strategies in clinical transplantation, autoimmune disease, and allergy. Articles will also cover the barriers to clinical tolerance induction and new emerging approaches to overcome such barriers.

1. Collaborative networks working towards the goal of therapeutic tolerance induction

2. Prope tolerance and minimization of immunosuppression

3. Lessons from operationally tolerant patients

4. Targeted withdrawal of immunosuppression

5. Stem cells and hematopoietic chimerism as a route to tolerance

6. Promoting regulatory T cells

7. Tolerogenic dendritic cells and negative vaccination

8. Inhibitory pathways and mechanisms in tolerance

9. Memory T cells and heterologous immunity

10. The innate response to allotransplants

11. Chronic graft loss--what are the missing links?

12. The impact of graft microenvironment on tolerance

Download ebook

Share

Editors

Stephen Paul Cobbold

University of Oxford

Houston Methodist Hospital

Impact

126,983 Total views

97,360 Article views

27,658 Article downloads

1,965 Topic views

Published In

Journal Thumbnail

Frontiers in Immunology

Immunological Tolerance and Regulation

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Suggest a topic